Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Sotagliflozin (LX4211) CAS：1018899-04-1
Sotagliflozin (LX4211)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1625 | 100mg | 425.00 | + Add to cart |
|
| R-C-1625 | 200mg | 600.00 | + Add to cart |
|
| R-C-1625 | 500mg | 1150.00 | + Add to cart |
|
|
|
||||
Product description
Sotagliflozin（LX4211)is an orally active and a dual SGLT1/SGLT2 inhibitor, which improves glycemic control in patients with type 2 diabetes in a randomized,placebo-controlled trial.LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1(SGLT1)-mediated absorption of intestinal glucose.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---Sotagliflozin (LX4211) Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
